Revisions of precautions for various drugs in Japan

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2007卷 / 1期

关键词：

D O I：

10.1007/s40278-024-58567-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：7 / 7

相关论文

共 50 条

[31] Common Antifungal Drugs in Pregnancy: Risks and Precautions
Patel, Madhuri A.
Aliporewala, Veeral M.
Patel, Disha A.
JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA, 2021, 71 (06): : 577 - 582
[32] Revision of precautions for drug package inserts in Japan
Reactions Weekly, 2023, 1939 (1) : 7 - 7
[33] Abiraterone acetate: revised precautions issued in Japan
Reactions Weekly, 2015, 1538 (1) : 1 - 1
[34] Revised driving precautions required for SNRIs in Japan
Reactions Weekly, 2016, 1631 (1) : 3 - 3
[35] Package insert revisions for three therapies in Japan
Reactions Weekly, 2018, 1727 (1) : 3 - 3
[36] Package insert revisions for apremilast, ceftriaxone in Japan
Reactions Weekly, 2018, 1715 (1) : 2 - 2
[37] PRECAUTIONS IN USE OF ANTIHYPERTENSIVE DRUGS, INCLUDING CHLOROTHIAZIDE
WILKINS, RW
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1958, 167 (07): : 801 - 807
[38] Common Antifungal Drugs in Pregnancy: Risks and Precautions
Madhuri A. Patel
Veeral M. Aliporewala
Disha A. Patel
The Journal of Obstetrics and Gynecology of India, 2021, 71 : 577 - 582
[39] PMDA recommends revised precautions for various products
Reactions Weekly, 2015, 1577 (1) : 5 - 5
[40] DRUG LABEL REVISIONS FOR TWO PSYCHIATRIC DRUGS
Aschenbrenner, Diane S.
AMERICAN JOURNAL OF NURSING, 2011, 111 (11) : 23 - 23

← 1 2 3 4 5 →